Steven Mitchell Kornblau

37PUBLICATIONS
240CO-AUTHORS
Cellular immunologyGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Apr 17, 2026
Intracellular IL-23R is necessary for mitotic spindle formation and viability in AML.

|Feb 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.

Samarpana Chakraborty, Claudia Morganti, Kimberly Zaldana

|Dec 10, 2025
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi

|Jun 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.

Courtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi

|Apr 02, 2025
VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial.

Mahesh Swaminathan, Courtney D DiNardo, Abhishek Maiti

|Feb 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi

Pageof 7

Frequent Collaborators

10 joint publications

Guillermo Garcia-Manero

10 joint publications

Gautam Borthakur

10 joint publications

Courtney DiNardo

10 joint publications

Marina Y Konopleva